Paper33247227
SON inhibits megakaryocytic differentiation via repressing RUNX1 and the megakaryocytic gene expression program in acute megakaryoblastic leukemia.
Vukadin L and 12 others. Cancer Gene Ther, 2021. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. SON inhibits megakaryocytic differentiation via repressing RUNX1 and the megakaryocytic gene expression program in acute megakaryoblastic leukemia. Papers, record 33247227. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33247227
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Core Binding Factor Alpha 2 Subunit | Major topic |
| DNA-Binding Proteins | Major topic |
| Leukemia, Megakaryoblastic, Acute | Major topic |
| Megakaryocytes | Major topic |
| Minor Histocompatibility Antigens | Major topic |
| Cell Differentiation | |
| Down Syndrome | |
| Gene Expression | |
| Genetic Predisposition to Disease | |
| Humans | |
| Transfection |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 CA236911 | NCI NIH HHS | United States | R01CA236911 | PubMed and NIH | NIH RePORTER |
| R01 CA243793 | NCI NIH HHS | United States | R01CA243793 | PubMed and NIH | NIH RePORTER |
| R21 CA236549 | NCI NIH HHS | United States | R21CA236549 | PubMed and NIH | NIH RePORTER |
| R01 CA190688 | NCI NIH HHS | United States | R01CA190688 | PubMed and NIH | NIH RePORTER |
| R01 HL136432 | NHLBI NIH HHS | United States | R01HL136432 | PubMed and NIH | NIH RePORTER |
References65
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12200673 | Acute megakaryoblastic leukemia: experience of GIMEMA trials. | Leukemia | 2002 | https://conductscience.org/library/papers/12200673 | PubMed |
| 2 | 10997960 | The management of neoplastic disorders of haematopoiesis in children with Down's syndrome. | Br J Haematol | 2000 | https://conductscience.org/library/papers/10997960 | PubMed |
| 3 | 11389009 | Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience. | Blood | 2001 | https://conductscience.org/library/papers/11389009 | PubMed |
| 4 | 16856158 | Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children's Oncology Group. | Pediatr Blood Cancer | 2007 | https://conductscience.org/library/papers/16856158 | PubMed |
| 5 | 15630411 | Origins of leukaemia in children with Down syndrome. | Nat Rev Cancer | 2005 | https://conductscience.org/library/papers/15630411 | PubMed |
| 6 | 26186939 | The biology of pediatric acute megakaryoblastic leukemia. | Blood | 2015 | https://conductscience.org/library/papers/26186939 | PubMed |
| 7 | 25155832 | Haematopoietic development and leukaemia in Down syndrome. | Br J Haematol | 2014 | https://conductscience.org/library/papers/25155832 | PubMed |
| 8 | 18812473 | Trisomy 21 enhances human fetal erythro-megakaryocytic development. | Blood | 2008 | https://conductscience.org/library/papers/18812473 | PubMed |
| 9 | 18689547 | Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations. | Blood | 2008 | https://conductscience.org/library/papers/18689547 | PubMed |
| 10 | 23045704 | Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cells. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/23045704 | PubMed |
| 11 | 23045701 | Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/23045701 | PubMed |
| 12 | 19597142 | The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19597142 | PubMed |
| 13 | 20697343 | Trisomic dose of several chromosome 21 genes perturbs haematopoietic stem and progenitor cell differentiation in Down's syndrome. | Oncogene | 2010 | https://conductscience.org/library/papers/20697343 | PubMed |
| 14 | 19487285 | ERG is a megakaryocytic oncogene. | Cancer Res | 2009 | https://conductscience.org/library/papers/19487285 | PubMed |
| 15 | 19168790 | ETS2 and ERG promote megakaryopoiesis and synergize with alterations in GATA-1 to immortalize hematopoietic progenitor cells. | Blood | 2009 | https://conductscience.org/library/papers/19168790 | PubMed |
| 16 | 20007548 | Trisomy of Erg is required for myeloproliferation in a mouse model of Down syndrome. | Blood | 2010 | https://conductscience.org/library/papers/20007548 | PubMed |
| 17 | 22354171 | Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome. | J Clin Invest | 2012 | https://conductscience.org/library/papers/22354171 | PubMed |
| 18 | 20194440 | miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia. | Genes Dev | 2010 | https://conductscience.org/library/papers/20194440 | PubMed |
| 19 | 16492768 | Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling. | Proc Natl Acad Sci U S A | 2006 | https://conductscience.org/library/papers/16492768 | PubMed |
| 20 | 24030980 | New discoveries of old SON: a link between RNA splicing and cancer. | J Cell Biochem | 2014 | https://conductscience.org/library/papers/24030980 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41300732 | A Case Report: Identification of a Pathogenic Microdeletion at Chromosome 21q21.3q22.13 Using Whole-Exome Sequencing and CNV Analysis in a Moroccan Child with Global Developmental Delay. | Genes (Basel) | 2025 | https://conductscience.org/library/papers/41300732 | PubMed |
| 40547921 | Novel perceptions and insights into the rare hematologic malignancy of acute megakaryocytic leukemia: a multicenter clinical retrospective study. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40547921 | PubMed |
| 39313574 | SON is an essential RNA splicing factor promoting ErbB2 and ErbB3 expression in breast cancer. | Br J Cancer | 2024 | https://conductscience.org/library/papers/39313574 | PubMed |
| 38867584 | Epigenetic regulation of megakaryopoiesis and platelet formation. | Haematologica | 2024 | https://conductscience.org/library/papers/38867584 | PubMed |
| 38602631 | Epigenetic mechanism of SET7/9-mediated histone methylation modification in high glucose-induced ferroptosis in retinal pigment epithelial cells. | J Bioenerg Biomembr | 2024 | https://conductscience.org/library/papers/38602631 | PubMed |
| 37670378 | RUN(X) out of blood: emerging RUNX1 functions beyond hematopoiesis and links to Down syndrome. | Hum Genomics | 2023 | https://conductscience.org/library/papers/37670378 | PubMed |
| 36035173 | Advances in molecular characterization of myeloid proliferations associated with Down syndrome. | Front Genet | 2022 | https://conductscience.org/library/papers/36035173 | PubMed |
| 34518645 | Clinical and biological aspects of myeloid leukemia in Down syndrome. | Leukemia | 2021 | https://conductscience.org/library/papers/34518645 | PubMed |
| 34440349 | Transcriptional Regulation of RUNX1: An Informatics Analysis. | Genes (Basel) | 2021 | https://conductscience.org/library/papers/34440349 | PubMed |
Genes54
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33247227
GET https://conductscience.org/api/papers/v1/33247227/references?page=2